Abstract
Chronic low-level uranium (U) exposure through drinking water is a public health risk in the United States. Nearly two-thirds of community water systems, serving 320 million people, have detectable U levels, with 2% exceeding the EPA's maximum contaminant level of 30 μg/L. Ingested U accumulates in kidneys and is nephrotoxic at high levels. Uranium binds to proximal tubule cells, causing injury and interfering with kidney function. Epidemiological studies suggest that even low-level (<30 μg/L) of U exposure could damage kidneys. Current biomarkers, like urinary U levels, fail to indicate tissue-specific concentrations and metabolic interactions in kidneys. Fractionation of (238)U/(235)U may potentially serve as a biomarker for the metabolic interaction of U with organs. Our experiments with mice showed changes in U isotopic composition ((238)U/(235)U expressed as δ(238)U) in organs after administering 50 mg/L U via drinking water for 2, 7, and 14 days. We found (235)U enrichment in kidneys and bones, the target organs, while urine was enriched in (238)U. Our results provide evidence of isotopic fractionation resulting from U accumulation in kidneys. Urinary U isotopic composition may, thus, provide a sensitive, noninvasive measurement of renal U bioaccumulation that could aid early detection of nephrotoxicity and prevention of irreversible kidney damage.